Pain management study designed to help patients reduce opioid use receives $8.8 million funding

SALT LAKE CITY, UTAH, USA, October 2, 2017 / — A team of researchers from Stanford Medicine and Intermountain Healthcare have been approved for a $8.8 million funding award by the Patient-Centered Outcomes Research Institute (PCORI). The study, is designed to test pain management treatment strategies that help patients with chronic pain reduce their use of opioids.

Stanford’s Beth Darnall, PhD, Clinical Professor of Anesthesiology, Perioperative and Pain Medicine will lead the study and coordinate with Intermountain’s site principal investigator Joel G. Porter, MD, a family practice physician.

The pain management study is one of several Stanford and Intermountain collaborative projects that support innovation in research, patient care, and medical education.

The study seeks to compare the effectiveness of psychologist led cognitive behavioral therapy (CBT), peer led chronic pain self-management classes, and providing no behavioral treatment in the context of reducing opioids for individuals with chronic pain.

Dr. Darnall, a pain psychologist and researcher, said people with chronic pain are often fearful about reducing opioid use. Tapering down moderate to high dose opioids while effectively managing pain, mood and function can be challenging for most individuals.

Study participants will begin a patient-centered program to taper their opioid use and will also be assigned to one of three groups: one will receive cognitive behavioral therapy, another will learn pain self-management techniques, and the third group will receive no behavioral treatment. The treatment strategies encourage the patient’s interest and willingness to actively and collaboratively reduce opioid use.

“With the collaboration between the Stanford and Intermountain and the support of the Institute, we have the potential to develop evidence-based treatment plans, tailored to meet the needs of individual patients,” says Dr. Porter. “Our goal is to deliver pain management care that helps our patients achieve meaningful and successful outcomes that last long term.”

“Alternatives are needed to reduce opioid risks and to provide pain relief to patients,” says Dr. Darnall, adding that her study aims to reduce opioid use compassionately while testing the effectiveness of behavioral treatment for pain. “We seek to provide physicians and patients with the evidence and tools they need to treat chronic pain with less opioids.”

Darnall’s study was selected for funding through a PCORI funding announcement specifically focused on long-term opioid use for people with chronic pain. There is a shortage of high-quality evidence demonstrating the safety and effectiveness of long-term opioid therapy for the management of chronic pain, and to date no large-scale studies have assessed strategies for managing and reducing chronic opioid use in real-world clinical settings. Input from a variety of stakeholders identified this research gap and helped PCORI to refine its call for research proposals.

“This project was selected for PCORI funding for its potential to fill an important gap in our understanding of long-term opioid therapy and to give people living with chronic pain useful information to help them weigh the effectiveness and safety of their care options,” said PCORI Executive Director Joe Selby, MD, MPH. “We look forward to following the study’s progress and working with Stanford to share the results.”

Dr. Beth Darnall’s award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract.

PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed healthcare decisions. For more information about PCORI’s funding, visit

Stanford Medicine integrates research, medical education and health care at its three institutions – Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at

Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, 180 clinics, a Medical Group with some 1,500 employed physicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit

Daron Cowley
Intermountain Healthcare
email us here

Source: EIN Presswire

New Female Driving Team Enter Super Car GB 2017

For 2017, Kaz Aston & HRH Princess Katarina of Serbia entered #SuperCarGB 2017 organised with Autumn & Peter Phillips

For continued enjoyment for 2017, the Berkshire group chair Kaz Aston & HRH Princess Katarina of Serbia entered #SuperCarGB 2017 This exclusive event organised with Autumn & Peter Phillips. ”

— Kaz Aston

WINDSOR, BERKSHIRE, UNITED KINGDOM, October 2, 2017 / — Berkshire Monarchy Group Latest 2017 Charity News

For continued enjoyment for 2017, the Berkshire group chair Karen Aston & HRH Princess Katarina of Serbia entered #SuperCarGB 2017 for the Berkshire CMA Group. This exclusive event organised with Autumn & Peter Phillips to drive with an all female charity CMA team, with a royal team member.
Firstly, we must thank again HRH Princess Katarina of Serbia for enabling the all girls team to enter and succeed on this mission, Supercar GB 2017- Route Dolomites. The charity drive in total covered over three thousand miles through six countries, in only 5 days and visited France, Austria, Italy, Switzerland and Croatia on our incredible dolomites route.
The team also very fortunate, thanks to sponsorship, to hire a special Audi R8 Supercar from London company, Hertz Dream Collection. So the CMA team felt absolutely delighted to complete the Dolomites in a British registered supercar and also support UK businesses, as part of the project. Consequently, the CMA team have helped two global education charities and enjoyed an absolutely amazing, fun summer in Berkshire, London and six European countries.
The Berkshire group continues to hold fun, colourful and charitable events with clear Royal links to promote education and a better understanding of the Monarchy in today’s society. Our next event is planned for the evening of November the 9th, in Kensington London. Here, the group will recognise and give awards to inspirational females nominated by the general public for, exceptional contributions to society.
For further information about the event or group meetings please contact group chair: Miss Karen Aston on 07768904878 or email:

karen aston
email us here

Source: EIN Presswire

Einstein's childhood building blocks and a musical manuscript signed by Mozart will be exhibited in New York City Oct. 7

Albert Einstein’s childhood set of Anker-Steinbaukasten building blocks.

Einstein letter written months before Hiroshima, in which he warns of the atomic bomb.

Thomas Jefferson’s handwritten scientific document, explaining Napier’s Theorum.

Einstein’s original letter counseling his son on the meaning of life and youth.

Hand-signed letters and manuscripts, and even the building blocks of Albert Einstein’s mind, will be at the center of a lecture and flash exhibit, October 7th.

Our documents and artifacts provide an authentic connection to the people, events and ideas that determine the course of history.”

— Seth Kaller

NEW YORK CITY, N.Y., UNITED STATES, October 2, 2017 / — NEW YORK CITY – Hand-signed letters and manuscripts, and even the building blocks of legendary theoretical physicist Albert Einstein’s mind will be at the center of a flash exhibit to accompany a lecture titled The Nature of Genius: From Michelangelo and Leonardo Da Vinci to Albert Einstein and Steve Jobs, on Saturday, October 7th at the New York Institute of Technology Theater on Broadway, from 9:30 am to 12:30 pm Eastern time.

The event is being offered by One Day University, as part of a series of thought-provoking lectures by renowned historians, scholars and authors. More than 60,000 people have already participated in One Day University events. This lecture will be given by Professor Craig Wright of Yale University, based on his highly sought-after course, Exploring the Nature of Genius.

The original artifacts are provided by Seth Kaller, Inc., a leading historic document dealer and collection-builder. Mr. Kaller, owner and president explains, “Our display will add to an already excellent program a new dimension of intimate, physical contact with our past. Our documents and artifacts provide an authentic connection to the people, events and ideas that determine the course of history.”

It is interesting to consider to what extent his environment, right down to his toys, helped contribute to Einstein’s genius. On display will be Einstein’s own set of Anker-Steinbaukasten building blocks, which descended in his family until last year, when they were acquired by Kaller.

Original documents pertaining to Wolfgang Amadeus Mozart and Thomas Jefferson will also be displayed. One Mozart item will be of particular interest, because of its rarity, high value and musical and historical significance. It’s a six-page complete musical manuscript, autographed by Mozart and titled La Bataille (K.535, a contredanse for orchestra). No place or date is provided, but what is known about Mozart’s remarkable life places the manuscript in Vienna, in Jan. 1788.

Craig Wright said of the piece, “Pound for pound, measure for measure, this brief, albeit complete, Mozart autograph is as historically interesting as any extant Mozart document. It tells us much about Mozart’s career and about the fate of the Holy Roman Empire in early 1788.” The manuscript, beautifully presented in a handsome in-binder, is valued at an estimated $1 million.

Einstein’s signed documents on display will include:

His handwritten letter counseling his son on the meaning of life and youth and the relative value of intellectual creations. “All my life I have troubled myself with problems and am always – as on the first day – inspired by the fact that cognition in the scientific and artistic sense is the best thing we possess,” Einstein wrote. “If one hears angels singing a couple of times during one’s life, one can give the world something and one is a particularly fortunate and blessed individual.”

A letter written eight months before Hiroshima, in which he warns that a “modern technological development” (clearly the still-secret atomic bomb) would lead to World War III. Einstein references a book that his friend, Dr. Isidore Held, had sent apparently opposing the creation of the United Nations. Einstein felt that new weapons would favor a first-strike pre-emptive war, and that international institutions were needed to prevent that. These thoughts and sentiments are just as timely today, in light of recent news events, as when Einstein first wrote them.

One Day University and Seth Kaller, Inc. have recently agreed to an exclusive partnership, with Kaller bringing powerful and extraordinary original historic documents to particular One Day University events. Their first joint exhibit, in September, was for Hamilton vs. Jefferson: The Rivalry That Shaped America.

A selection from Seth Kaller Inc.’s inventory can be seen on Kaller can be reached at (914) 289-1776; or, by e-mail to

Admission to The Nature of Genius: From Michelangelo and Leonardo Da Vinci to Albert Einstein and Steve Jobs is $80. The New York Institute of Technology Theater is located at 1871 Broadway in New York City. For more information about the event, visit

Scott Usher
Seth Kaller, Inc.
(203) 448-8065
email us here

Source: EIN Presswire

Real Estate Services Across World Soaring with GREL’s NEW Capital Award System

capital award system by GREL


Global Real Estate Licence, the provider of online real estate education & technology solutions, today announced the launch of The Capital Award System.

PALO ALTO, CALIFORNIA, UNITED STATES, October 2, 2017 / — Global Real Estate Licence, the provider of online real estate education & technology solutions, is pleased to announce The Capital Award system. Remarkable agents will be the wave of the future with this award being designed for top agents from around the world. They will be awarded a spot on the real estate platform website,, for powerful recognition from fellow passionate agents. These agents will be recognized and appreciated in their communities and looked up to by other agents. GREL is seeking out those top closing, innovative, powerful marketers, with a passionate attitude for real estate.

“If you pay attention to the life of an agent, their adaptation to their surrounding will amaze you. Forced to play different roles, keep track of deals, work with clients, negotiate, and move the industry, it’s not a career that is cut out for just any body. There's a tremendous amount of discipline and sacrifice agent’s must maintain, which is not so obvious from the outside. We have created these awards because we recognize the amount of skill and talent it takes to become a top agents. Their status is a symbol of consumer trust they have built over the span of their careers, which can only be as a result of the value they add in their markets, and for that, they we are happy to reward them with recognition.”

Being recognized by GREL as The Capital Award winner will initiate a sense of entitlement and honor which can be shown to clientele as something that surpasses a reference, but as ovation worthy. The agents whom are awarded will be those who are not just great, but superb in the industry of real estate. They must be leaders who are willing and striving to provide the highest quality real estate services for their clientele while changing the industry in a positive manner. You are the future of real estate, and let GREL be your guide.

Tim Grant
Global Real Estate Licence
email us here

Source: EIN Presswire

2017 Georgia Legislative Policy Forum is October 13

Transforming Health Care and Education

Transformative ideas for Georgia in health care and education”

— Georgia Public Policy Foundation

ATLANTA, GEORGIA, USA, October 2, 2017 / — Don't miss the "opening shot" to Georgia's legislative session!

Registration is open now for the 2017 Georgia Legislative Policy Forum on Friday, October 13 from 7:30 a.m. to 3 p.m. at the Renaissance Atlanta Waverly Hotel.

Join policymakers, educators, elected officials, candidates and concerned citizens as some of the nation's top experts share transformative ideas for Georgia in health care and education.

The theme is “Wisdom, Justice, Transformation,” a take on the State of Georgia motto, “Wisdom, Justice, Moderation."

The keynote speaker is Dr. Tim Huelskamp, former Congressman and the dynamic new president of The Heartland Institute.

Access the event Agenda and Registration here.

This event is open to the public; the registration rate of $125 includes breakfast and lunch.

Read the Foundation's commentary, "2017 Legislative Policy Forum: Transforming Education, Health Care."


*Success Across the State: Examples of Health Care Transformation in Georgia

**Laboratories of Democracy: Health Care Transformation through Federal Waivers

***Education Transformation: Unleashing the Teacherpreneurs and Edupreneurs

Sponsorships available; contact Benita Dodd. Media who wish to attend must contact Benita Dodd.

Benita Dodd
Georgia Public Policy Foundation
email us here

“Opening Short” to the legislative session

Source: EIN Presswire

The First Full-Time Employee at MarketCrest, LLC Reaches One Year of Employment

MarketCrest Logo

Rachel Thomas Marks One Year at MarketCrest Marketing Firm

Marketing Coordinator, Rachel Thomas, Reaches One Year of Employment at MarketCrest, LLC

I have been able to experience extreme personal and professional growth, while simultaneously playing a huge part in the growth of the company”

— Rachel Thomas

MCKINNEY, TX, UNITED STATES, October 2, 2017 / — MarketCrest, LLC has some exciting news to celebrate! This week, Rachel Thomas, the first full-time employee of the company, reached her one-year milestone as Marketing Coordinator.

MarketCrest, LLC is a boutique marketing firm that specializes in digital marketing, including: consulting, marketing strategy & research, search engine optimization, social media marketing, paid and unpaid promotions, content creation (blogs, videos, web-copy, press releases, case studies, ebooks, etc.), web design, lead generation and more.

The role of Marketing Coordinator duties includes management of the agencies team of copy-writers and oversight of all content marketing strategy and creation.

Thomas, a University of North Texas graduate, has a bachelor’s degree in Strategic Communications and minors in Marketing and Social Science.

Her educational background, sharp and creative mind, and ability to flourish customer relationships makes her excel in the positon.

“My time at MarketCrest has been invaluable to me because I have been able to experience extreme personal and professional growth, while simultaneously playing a huge part in the growth of the company, said Thomas.

Since hiring Thomas, MarketCrest, LLC has more than doubled in size.

The company growth has included acquiring office space, hiring more full-time marketing staff, gaining incredible clients, and winning multiple marketing awards.

About MarketCrest, LLC:

MarketCrest, LLC is an award winning, full-service marketing firm focused exclusively on Marketing Consulting & Services that drive revenue growth. Simply, we exist to help our clients compete and grow… and we expect to be held accountable for their improved performance.

For more information please call (469) 661-1040 or visit the website at

Rachel Thomas
email us here

Source: EIN Presswire

Already saving lives from fungal disease – GAFFI’s 4-year legacy

Dr. Lourdes Fong, Directora Unidad de Atención Integral Petén, Guatemala

with the support of the GAFFI proposal, in less than 24 hours and in only 3 months, we have diagnosed and treated 17 patients with a fungal or TB infection.”

— Dr. Lourdes Fong

MANCHESTER, UNITED KINGDOM, October 2, 2017 / — The Global Action Fund for Fungal infections, GAFFI,has been operational for 4 years and among its many successes, none is more important or indicative of its work, than directly saving lives in Guatemala. This program of implementing well known diagnostic tests in a reference laboratory, has picked up 139 life-threatening fungal infections in AIDS. By also ensuring all the antifungal drugs are also available, and educating the doctors about fungal disease. This program covers the whole country. And other Latin American countries plan to mirror it – in Panama, Salvador, Nicaragua, Honduras and Ecuador. GAFFI’s new brochure outlining the problems, and its solutions has just been launched in English and Spanish.

HIV carries much stigma in Guatemala. One of the patients who benefitted from the GAFFI program said: “I am César, I am 35 years old. I used to work in a cattle farm, over 450 km from the capital of Guatemala. At first, I had a lot of headaches, a fever and sweating at night. I feel so bad that I even lost consciousness. Because of this I went to a public hospital where the doctors told me that I had cryptococcal (fungal) meningitis. There they helped me and I received treatment. At present, I feel good and I want to start working again. I am very grateful for the care I received from the doctors and the GAFFI project.”

Dr. Lourdes Fong, Directora Unidad de Atención Integral Petén, Guatemala said “The HIV care unit, which I am in charge, is located 465 km from Guatemala City, in one of the most remote parts of the country, near the Tikal ruins. In our HIV Unit, one year ago we only diagnosed five patients with an opportunistic infection; but now with the support of the GAFFI proposal, in less than 24 hours and in only 3 months, we have diagnosed and treated 17 patients with a fungal or TB infection. The patients have benefited greatly and improved their survival and also their response to anti-HIV treatment.”

Professor David Denning, GAFFI’s President, also of The University of Manchester, stated: “GAFFI is primarily focused on evidenced-based advocacy to improve the outcomes of patients with fungal diseases, across the world. The national fungal diagnostic program in Guatemala is the first in the world and will be followed by others, Kenya and hopefully Uganda. By showing that the combination of rapid diagnosis and access to antifungal medicine in the hands of educated doctors saves lives, is GAFFI’s main middle term aim.” He has recorded a message with detailed comments.

GAFFI has also:
• Developed a 10-year global Roadmap for improving fungal disease diagnosis and management (95-95 by 2025)
• Shown that 1,600,000 lives could be saved from fungal infections in AIDS with 60% coverage of fungal diagnostics & drugs
• Successfully argued for 5 antifungal agents to be accepted onto the WHO Essential Medicines List (adult and child)
• Estimated the burden of serious fungal diseases in 71 countries (>80% of the global population)
• Published the lack of availability and huge price variations for all 6 critical antifungals
• Persuaded the WHO to include chromoblastomycosis and other tropical fungal diseases to be on the Neglected Tropical Disease list
• Argued the case for fungal diagnostics being a key component in fighting antimicrobial resistance (AMR).

Notes to Editors:

Notes to Editors:
For more information please contact Susan Osborne, Director of Communications, The Goodwork Organisation on Tel: (+44 (0) 7836 229208) or via email on

GAFFI is a charitable foundation (NGO) focused on reducing deaths and illness caused by fungal disease. Fungal diseases are neglected worldwide by public health authorities. GAFFI efforts are directed at:

1. Identifying and publicising gaps in diagnostics and treatments for fungal diseases.
2. Consulting on how healthcare could be improved through facilitating training, encouraging companies to expand their markets and recommending improvements in infrastructure.
3. Estimating the burden of serious fungal diseases, country by country. Over 68 country estimates are complete, and many of these are published
4. Developing, implementing and evaluating countrywide diagnostic programs – Guatemala (fungal infections in AIDS) the first.
5. Influencing national and international agencies to ‘adopt’ fungal diseases alongside existing programs including TB, microbiology, AMR, NTDs and incorporation of key generic antifungals onto the WHO Essential Medicines List.
6. Focusing diagnostic improvements for GAFFI’s priority diseases.

GAFFI issued a 10-year Roadmap in 2015 calling for ‘95-95 by 2025’, summarized as 95 per cent of patients with serious fungal infections are diagnosed and treated.

Susan Osborne
Goodwork, Director of Communications
+44 (0)208 747 1488
email us here

Source: EIN Presswire


Jim Benkendorf

Luke Moyer

Ravi Kiron

BSMA's 10th Annual Conference will address how collaboration for optimization at the head end of the supply chain is an imperative.

It was heartening to see so many of the attendees speak so highly of what you have accomplished for the Global Supply Chain space over the years and be their voice to enhance awareness and support….”


CALABASAS, CALIFORNIA, USA, October 1, 2017 / — Foster City, California, September 27, 2017: Eminent executives of the bio-pharma industry will focus on how to meet the formidable challenges of drug development. A 2014 study done by the Tufts Center for the Study of Drug Development indicated that developing a new prescription medicine that gains marketing approval, a process often lasting more than a decade, is estimated to cost $2.6 billion. The 10th Annual Conference of BSMA on October 12, 2017 in Foster City, CA titled “DRIVING INNOVATIONS & TECHNOLOGY TRANSFORMING BIO-PHARMA”, will address how collaboration for optimization at the head end of the supply chain is an imperative. Technology enablers and service providers are facilitating the adoption of disruptive technologies of digital, Internet, data analytics and artificial intelligence to reduce cost of medicine and time to market. For details of the conference program, Click Here.

“Outsourcing the Clinical Supply Chain: Is a Single Provider Strategy the Solution?”
Under pressure to jumpstart productivity and reduce the time and cost of shepherding new drugs from laboratory through licensure, the biopharmaceutical industry began globalizing clinical trials about 15 years ago. This continued globalization has precipitated a spike in the operational and strategic obstacles faced by clinical trial professionals. Outsourcing models are discussed – multiple vendors versus single provider, with case study examples and guidance on top tips for success. The critical challenges faced by startup, small and mid-sized companies will also be addressed.
Jim Benkendorf, General Manager, Fisher Clinical Services

“Navigating the ASIA-PACIFIC Clinical Supply Chain for Accelerated & Efficient Drug Development”
Representing 60% of the world’s population, Asia continues to rise to the forefront of the clinical trial arena with an estimated 25% of global clinical trials taking place in Asian countries. The presentation will highlight unique clinical supply chain challenges and strategies required to achieve success for the conduct of trials in this varied and nuanced regulatory landscape.
Luke Moyer, Supply Chain Solutions Manager, Almac

"Integrating Planning and Logistics to Maximize Effectiveness of Clinical Trials Through a Data-driven, Systems Approach"
Solutions of Information Technology drive the holy grail of clinical supply chain which ties all stakeholders together for speed to market, improved outcomes of clinical trials and cost efficiency. This panel will address how operations planning, information systems, business practices and collaboration are improving the outcomes, accountability and visibility in the supply chain consisting of clinical operations and clinical supply with trials management and 3rd party service providers. Topics covered will include patient enrollment forecasting and real time updating, managing inventory with MRP and performing drug accountability and reconciliation, including returns.

• Bill Coakley, Senior Director, Global Supply Chain, BioMarin
• Kevin Shea, Senior Label Program Director, Clintrak Clinical Labeling
• Moderator: Ravi Kiron, Head, BioPharma External Innovation West Coast, EMD Serono

Conference Overview:
Since the inception of BSMA ten years ago, the conference has been recognized to be the most informative, interactive, technology-enabling and solution-sharing event in the bio-pharma space where drug manufacturers lead, academia provides research, and service providers build the extended supply chain. The collaboration with Biocom, Biomedical Manufacturing Network, the City of Fremont, CSCMP and the Keck Graduate Institute, is driven by the mission to empower small and mid-sized companies to further the resurgence of manufacturing in California.

Devendra Mishra
Bio Supply Management Alliance
email us here

BSMA Launches in Boston, 2017

Source: EIN Presswire

هل تحسنت مستويات الأمن والسلامة على طرقات الإمارات العربية المتحدة؟

النسخة الخامسة من دراسة Road Safety UAE

ويجيب توماس إيدلمان، المؤسس والمدير الإداري لموقع (RoadSafetyUAE) للسلامة المرورية، على هذا التساؤل بالقول: "نعم، يمكن القول أن المؤشرات تبدو إيجابيةً”

— توماس إيدلمان

DUBAI, UAE, October 1, 2017 / — صدرت النسخة الخامسة من دراسة السلامه على طرقات دولة الامارات العربه المتحده وذلك تحت عنوان ’هل تحسنت مستويات الأمن والسلامة على طرقات دولة الإمارات العربية المتحدة؟‘، وتتناول هذه الدراسة مدى تحسن مستويات السلامة الطرقية في البلاد حيث شهد الاستطلاع الذي تم إجراؤه خلال العام الحالي مشاركة فاعلة من جميع أصحاب المصلحة المعنيين بتحسين السلامة الطرقية، ولكن يبقى السؤال المطروح يتمحور حول رأي المشاركين في الحركة المرورية، وفيما إذا كان السائقون سيدركون أهمية تحسين سلوكيات القيادة على الطرقات.
ويجيب توماس إيدلمان، المؤسس والمدير الإداري لموقع (RoadSafetyUAE) للسلامة المرورية، على هذا التساؤل بالقول: "نعم، يمكن القول أن المؤشرات تبدو إيجابيةً. فللمرة الأولى بتاريخ هذه الدراسة (والتي بدأت عام 2015) تشير على ان جميع التوجهات السلوكية المتعلقة بالقيادة تسير في الاتجاه الصحيح، حيث لاحظ السائقون في دولة الإمارات تراجعاً في الانحراف بين المسارات وانخفاضاً في سرعة القيادة وأنماط القيادة المشتتة وحالات عدم ترك مسافة أمان؛ فضلاً عن انخفاض مستويات أنماط القيادة المتهورة. وبالرغم من هذه التوجهات الإيجابية، ثمة الكثير من العمل الذي ينبغي القيام به، إذ لا تزال المستويات المطلقة للأنماط السلوكية السيئة مرتفعة. لذلك ينبغي الحفاظ على وتيرة الجهود الحثيثة التي يبذلها جميع أصحاب المصلحة المعنيون ولاسيما تلك المتعلقة بالتعليم ورفع الوعي حول السلوكيات الملائمة.
علاوة على ذلك، شهدت المدة الزمنية اللازمة للتنقل اليومي انخفاضاً ملموساً، في حين تراجع عدد المشاركين في الاستطلاع ممن أشاروا إلى تعرضهم للحوادث خلال فترة إجراء هذه الدراسة الاستقصائية بالمقارنة مع جميع الفترات السابقة للدراسة.
ومما يثير الدهشة ويعاكس التوجه الذي استمر لفترة طويلة،مما أشار السائقون في دولة الإمارات إلى تراجع مستويات السعادة في تجربة القيادة عموماً، ونوّهوا إلى أهمية تحسين البنى التحتية الخاصة بالطرقات.
وأضاف إيدلمان: "لا شك أن قياس تأثيرات إجراءات تحسين السلامة الطرقية يشكل أمراً بالغ الصعوبة، ونحن نعتقد بأن هذه الدراسة الاستقصائية طويلة الأمد تمثل أداة رائعة لتوفير تغذية راجعة يستفيد منها أصحاب المصلحة المعنيون، بما في ذلك الهيئات الحكومية ووسائل الإعلام والشركات، فضلاً عن منصات التوعية مثل موقع (RoadSafetyUAE). وفي هذا الإطار، تسلط هذه الدراسة الضوء على التوجهات المرتبطة بالمسببات الرئيسية لحدوث الوفيات على الطرقات، وذلك لتوفير الكثير من المعلومات لتحسين السلامة الطرقية ".
أبرز نتائج النسخة الخامسة من استطلاع Road Safety UAE:
تم إجراء هذه الدراسة بتكليف من موقع RoadSafetyUAE و’QIC Insured‘، وتولّت شركة ’يوجوف‘ إعدادها خلال شهر أغسطس 2017 استناداً إلى آراء عينة بلغ عدد أفرادها 1,010 أشخاص من المقيمين في الإمارات.
سجّل السائقون في دولة الإمارات خلال الأشهر الستة الماضية التوجهات الإيجابية التالية:
– انخفضت معدلات القيادة الخطرة: -8%
– تراجع حالات عدم ترك مسافة أمان: -12%
– انخفاض أعداد السائقين المشتتين: -10%
– تراجع حالات الانحراف بين المسارات: -9%
– انخفاض حالات السرعة الزائدة: -7%
– تراجع الحوادث: -5%
– انخفاض المدة الزمنية اللازمة للتنقل: -10%
وتجد الإشارة إلى أنه بالرغم من هذه التوجهات الإيجابية، فإن المستويات المطلقة للأنماط السلوكية السيئة لا تزال مرتفعة جداً.
وتأتي التوجهات السلبية المتعلقة بالنواحي التالية لتعاكس التوجهات الإيجابية الواردة أعلاه:
– تراجع مستويات السعادة في تجربة القيادة: -5%
– تراجع في مستويات تحسن البنى التحتية الطرقية: شهد هذا التوجه انخفاضاً بلغ -5% بالمقارنة مع النسخة السابقة للاستطلاع. ورغم ذلك فقد بلغت النسبة المطلقة للمشاركين في الاستطلاع ممن أشاروا إلى تحسن البنى التحتية 78%.

Fatma K Al Nasr
974 44962347
email us here

Source: EIN Presswire